Formulation Development and Evaluation of Pravastatin-Loaded Nanogel for Hyperlipidemia Management

Overview

Journal Gels

Date 2022 Feb 24

PMID 35200462

Authors

Gaurav Kant Saraogi

Siddharth Tholiya

Yachana Mishra

Vijay Mishra

Aqel Albutti

Pallavi Nayak

Murtaza M Tambuwala

Affiliations

Soon will be listed here.

Abstract

Hyperlipidemia is a crucial risk factor for the initiation and progression of atherosclerosis, ultimately leading to cardiovascular disease. The nanogel-based nanoplatform has emerged as an extremely promising drug delivery technology. Pravastatin Sodium (PS) is a cholesterol-lowering drug used to treat hyperlipidemia. This study aimed to fabricate Pravastatin-loaded nanogel for evaluation of its effect in hyperlipidemia treatment. Pravastatin-loaded chitosan nanoparticles (PS-CS-NPs) were prepared by the ionic gelation method; then, these prepared NPs were converted to nanogel by adding a specified amount of 5% poloxamer solution. Various parameters, including drug entrapment efficacy, in vitro drug release, and hemolytic activity of the developed and optimized formulation, were evaluated. The in vitro drug release of the nanogel formulation revealed the sustained release (59.63% in 24 h) of the drug. The drug excipients compatibility studies revealed no interaction between the drug and the screened excipients. Higher drug entrapment efficacy was observed. The hemolytic activity showed lesser toxicity in nanoformulation than the pure drug solution. These findings support the prospective use of orally administered pravastatin-loaded nanogel as an effective and safe nano delivery system in hyperlipidemia treatment.

Citing Articles

Pharmacodynamic Studies of Pravastatin Sodium Nanoemulsion Loaded Transdermal Patch for Treatment of Hyperlipidemia.

Elsayed S, El-Dahan M, Girgis G AAPS PharmSciTech. 2024; 25(2):34.

PMID: 38332233 DOI: 10.1208/s12249-024-02746-5.

Three-Dimensional In Vitro Tumor Spheroid Models for Evaluation of Anticancer Therapy: Recent Updates.

Nayak P, Bentivoglio V, Varani M, Signore A Cancers (Basel). 2023; 15(19).

PMID: 37835541 PMC: 10571930. DOI: 10.3390/cancers15194846.

Research progress on the therapeutic effects of nanoparticles loaded with drugs against atherosclerosis.

Shi T, Liu K, Peng Y, Dai W, Du D, Li X Cardiovasc Drugs Ther. 2023; 38(5):977-997.

PMID: 37178241 DOI: 10.1007/s10557-023-07461-0.

Fabrication of Novel Omeprazole-Based Chitosan Coated Nanoemulgel Formulation for Potential Anti-Microbia; In Vitro and Ex Vivo Characterizations.

Ullah I, Alhodaib A, Naz I, Ahmad W, Ullah H, Amin A Polymers (Basel). 2023; 15(5).

PMID: 36904539 PMC: 10007571. DOI: 10.3390/polym15051298.

Voriconazole Cyclodextrin Based Polymeric Nanobeads for Enhanced Solubility and Activity: In Vitro/In Vivo and Molecular Simulation Approach.

Farooq M, Usman F, Naseem M, Aati H, Ahmad H, Manee S Pharmaceutics. 2023; 15(2).

PMID: 36839711 PMC: 9968121. DOI: 10.3390/pharmaceutics15020389.

References

Jarvinen K, Jarvinen T, Thompson D, Stella V . The effect of a modified beta-cyclodextrin, SBE4-beta-CD, on the aqueous stability and ocular absorption of pilocarpine. Curr Eye Res. 1994; 13(12):897-905. DOI: 10.3109/02713689409015093. View

Murphy C, Deplazes E, Cranfield C, Garcia A . The Role of Structure and Biophysical Properties in the Pleiotropic Effects of Statins. Int J Mol Sci. 2020; 21(22). PMC: 7699354. DOI: 10.3390/ijms21228745. View

Xu H, Xu X, Li S, Song W, Yu D, Bligh S . The Effect of Drug Heterogeneous Distributions within Core-Sheath Nanostructures on Its Sustained Release Profiles. Biomolecules. 2021; 11(9). PMC: 8469915. DOI: 10.3390/biom11091330. View

Ludwig A . The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev. 2005; 57(11):1595-639. DOI: 10.1016/j.addr.2005.07.005. View

Korani S, Korani M, Bahrami S, Johnston T, Butler A, Banach M . Application of nanotechnology to improve the therapeutic benefits of statins. Drug Discov Today. 2018; 24(2):567-574. DOI: 10.1016/j.drudis.2018.09.023. View

Grimaudo M, Concheiro A, Alvarez-Lorenzo C . Nanogels for regenerative medicine. J Control Release. 2019; 313:148-160. DOI: 10.1016/j.jconrel.2019.09.015. View

Manzoni M, Rollini M . Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs. Appl Microbiol Biotechnol. 2002; 58(5):555-64. DOI: 10.1007/s00253-002-0932-9. View

Sivaram A, Rajitha P, Maya S, Jayakumar R, Sabitha M . Nanogels for delivery, imaging and therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015; 7(4):509-33. DOI: 10.1002/wnan.1328. View

Kao H, Lin H, Lo Y, Yu S . Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles. J Pharm Pharmacol. 2006; 58(2):179-86. DOI: 10.1211/jpp.58.2.0004. View

10.

Duran-Lobato M, Carrillo-Conde B, Khairandish Y, Peppas N . Surface-modified P(HEMA-co-MAA) nanogel carriers for oral vaccine delivery: design, characterization, and in vitro targeting evaluation. Biomacromolecules. 2014; 15(7):2725-34. PMC: 4504688. DOI: 10.1021/bm500588x. View

11.

Endo A . A historical perspective on the discovery of statins. Proc Jpn Acad Ser B Phys Biol Sci. 2010; 86(5):484-93. PMC: 3108295. DOI: 10.2183/pjab.86.484. View

12.

Mishra V, Jain N . Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits. Int J Pharm. 2013; 461(1-2):380-90. DOI: 10.1016/j.ijpharm.2013.11.043. View

13.

Wang H, Deng H, Gao M, Zhang W . Self-Assembled Nanogels Based on Ionic Gelation of Natural Polysaccharides for Drug Delivery. Front Bioeng Biotechnol. 2021; 9:703559. PMC: 8322728. DOI: 10.3389/fbioe.2021.703559. View

14.

Sharma A, Garg T, Aman A, Panchal K, Sharma R, Kumar S . Nanogel--an advanced drug delivery tool: Current and future. Artif Cells Nanomed Biotechnol. 2014; 44(1):165-77. DOI: 10.3109/21691401.2014.930745. View

15.

Vashist A, Kaushik A, Vashist A, Bala J, Nikkhah-Moshaie R, Sagar V . Nanogels as potential drug nanocarriers for CNS drug delivery. Drug Discov Today. 2018; 23(7):1436-1443. PMC: 6598698. DOI: 10.1016/j.drudis.2018.05.018. View

16.

Cuggino J, Blanco E, Gugliotta L, Alvarez Igarzabal C, Calderon M . Crossing biological barriers with nanogels to improve drug delivery performance. J Control Release. 2019; 307:221-246. DOI: 10.1016/j.jconrel.2019.06.005. View

17.

Mishra V, Gupta U, Jain N . Influence of different generations of poly(propylene imine) dendrimers on human erythrocytes. Pharmazie. 2011; 65(12):891-5. View

18.

Nelson R . Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care. 2013; 40(1):195-211. PMC: 3572442. DOI: 10.1016/j.pop.2012.11.003. View

19.

Desai K . Chitosan Nanoparticles Prepared by Ionotropic Gelation: An Overview of Recent Advances. Crit Rev Ther Drug Carrier Syst. 2016; 33(2):107-58. DOI: 10.1615/CritRevTherDrugCarrierSyst.2016014850. View

20.

Yin Y, Hu B, Yuan X, Cai L, Gao H, Yang Q . Nanogel: A Versatile Nano-Delivery System for Biomedical Applications. Pharmaceutics. 2020; 12(3). PMC: 7151186. DOI: 10.3390/pharmaceutics12030290. View